Home › Trial NCT00080678
Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases
- Trial IDNCT00080678
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorM.D. Anderson Cancer Center
- Enrollment116
- Start date2003-05
- ConditionsMetastatic Cancer · Prostate Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.